Key facts
- It has raised $760K.
- Notable investors include Semilla Ventures, CDTM Ventures, Ganas Ventures, Mujeres Empresarias, Platanus Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Neopausia
- ·The full record, as it builds
Funding rounds
No funding rounds for Neopausia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neopausia
Provider of digital health services intended for midlife hormonal care. The company offers online consultations with specialized doctors and nutritionists, personalized therapy plans, symptom tracking tools, educational courses, and monthly product delivery, enabling women experiencing menopause to access tailored support, reduce symptom intensity, and manage their health from home without delays or in-person visits.
- Sector
- Healthcare
- HQ
- Las Condes, Chile
- Founded
- 2024
- Employees
- 4
- Website
- neopausia.com/
- Ownership
- Privately Held (backing)
Neopausia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neopausia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neopausia in its N-PORT filings yet. We sweep new filings monthly.